FDA approves Brilinta 60 mg tablets CRN supports FDA action against marketing pure powdered caffeine to consumers McKesson public policy forum encourages pharmacists to get involved FDA unveils draft guidance for naming biosimilars FDA approves Synjardy tablets E-prescribing controlled substances now legal nationwide NACDS honors two chains for political advocacy Educating policy-makers to effect Rx change Primary care regains momentum amid innovation States spawn a patchwork of reform rules First Previous 56 57 58 59 60 Next Last
